Buchang Group
Buchang is China's leading cardiovascular and cerebrovascular pharmaceutical group. It is also the pharmaceutical group with most Chinese medicine patents and most patented herbal products in the world. The unique products, which are well protected by patents, bring it higher profitability than its counterparts. Also, its leading marketing networks in China help it build up strong platform value in China's pharmaceutical industry. The company was listed on the main board of A share market on November 2016, the code is SH:603858. TDR exited its investment through IPO in China's A Share market in Nov 2017.
Pengai Hospital Group
Pengai Hospital Group is engaged in the cosmetic medical treatment business through hospitals and clinics which conduct both surgical and non-surgical procedures. The group is one of the largest privately-owned cosmetic surgery hospitals in China. TDR Capital exited its investment through trade sale on December 2016.
ET Medical
ET Medical is a leading researcher, manufacturer and operator of gamma ray medical equipment in China with high growth and handsome profit margin. ET has unique business model of operating the Gamma knife Centers, and it has self-owned intellectual property and patents. TDR Capital exited its investment through trade sale.